1 – 10 of 13
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2011
-
Mark
Can sulphonylurea addition to lifestyle changes help to delay diabetes development in subjects with impaired fasting glucose? The Nepi ANtidiabetes StudY (NANSY)
(
- Contribution to journal › Article
- 2008
-
Mark
Low 5-year incidence of retinopathy in subjects with impaired fasting glucose (IFG), the NANSY-Eye Study
2008) 44th EASD Annual Meeting of the European Association for the Study of Diabetes In Diabetologia 51(S1). p.477-477(
- Contribution to journal › Published meeting abstract
-
Mark
Retinopathy in subjects with impaired fasting glucose The NANSY – Eye Study, Baseline report
(
- Contribution to journal › Article
- 2006
-
Mark
Utilisation of antihyperglycaemic drugs in ten European countries: different developments and different levels.
(
- Contribution to journal › Article
- 2005
-
Mark
Inverse association between plasma homocysteine, sulphonylurea exposure and physical activity: a community-based sample of type 2 diabetes patients in the Skaraborg hypertension and diabetes project
(
- Contribution to journal › Article
- 2004
-
Mark
Kinetics-effect relations of insulin-releasing drugs in patients with type 2 diabetes
(
- Contribution to journal › Article
- 2003
-
Mark
Metabolic disorders associated with uncontrolled hypertension.
(
- Contribution to journal › Article
- 2002
-
Mark
Efficacy, effectiveness and safety of sulphonylurea-metformin combination therapy in patients with type 2 diabetes.
(
- Contribution to journal › Scientific review
-
Mark
Survival in patients with type 2 diabetes in a Swedish community: skaraborg hypertension and diabetes project.
(
- Contribution to journal › Article
-
Mark
Glycaemic control, disease duration and beta-cell function in patients with Type 2 diabetes in a Swedish community. Skaraborg Hypertension and Diabetes Project.
(
- Contribution to journal › Article